(Q38374808)

2 September 2017

title

ATP citrate lyase is increased in human breast cancer, depletion of which promotes apoptosis (English)

1 reference

2 September 2017

Diyu Wang

1

1 reference

2 September 2017

Lei Yin

2

1 reference

2 September 2017

Jinrong Wei

3

1 reference

2 September 2017

Zhixue Yang

4

1 reference

2 September 2017

Guoqin Jiang

5

1 reference

2 September 2017

language of work or name

1 reference

1 April 2017

1 reference

2 September 2017

1 reference

2 September 2017

volume

39

1 reference

2 September 2017

issue

4

1 reference

2 September 2017

page(s)

1010428317698338

1 reference

Breast cancer as a global health concern.

2 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1010428317698338

ATP citrate lyase inhibition can suppress tumor cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317698338

The biology of cancer: metabolic reprogramming fuels cell growth and proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317698338

Nuclear PKM2 expression predicts poor prognosis in patients with esophageal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317698338

Metabolic cancer biology: structural-based analysis of cancer as a metabolic disease, new sights and opportunities for disease treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317698338

Targeting aspartate aminotransferase in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317698338

Targeting mitochondrial citrate transport in breast cancer cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317698338

Understanding the Warburg effect: the metabolic requirements of cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317698338

ATP-citrate lyase links cellular metabolism to histone acetylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317698338

Cytosolic functions of MORC2 in lipogenesis and adipogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317698338

Inhibition of ATP citrate lyase induces an anticancer effect via reactive oxygen species: AMPK as a predictive biomarker for therapeutic impact

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317698338

Prognostic Value of Malic Enzyme and ATP-Citrate Lyase in Non-Small Cell Lung Cancer of the Young and the Elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317698338

ATP-citrate lyase: a mini-review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317698338

ATP-citrate lyase deficiency in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317698338

Co-ordinate activation of lipogenic enzymes in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317698338

Prognostic and therapeutic implications of increased ATP citrate lyase expression in human epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317698338

Lipogenetic and glycolytic enzyme activities in carcinoma and nonmalignant diseases of the human breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317698338

Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317698338

The identification of ATP-citrate lyase as a protein kinase B (Akt) substrate in primary adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317698338

Decreased Warburg effect induced by ATP citrate lyase suppression inhibits tumor growth in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317698338

ATP-citrate lyase: a key player in cancer metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317698338

ATP citrate lyase: activation and therapeutic implications in non-small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317698338

Metastatic progression and gene expression between breast cancer cell lines from African American and Caucasian women

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317698338

ATP citrate lyase mediates resistance of colorectal cancer cells to SN38.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317698338

The EGF receptor family as targets for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317698338

Increased expression of c-erbB-2 in hormone-dependent breast cancer cells inhibits cell growth and induces differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317698338

The ErbB signaling network in embryogenesis and oncogenesis: signal diversification through combinatorial ligand-receptor interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317698338

PAK1 is a breast cancer oncogene that coordinately activates MAPK and MET signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317698338

Controlled dimerization of ErbB receptors provides evidence for differential signaling by homo- and heterodimers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317698338

Increased lipogenesis in cancer cells: new players, novel targets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317698338

Hormone receptor status, tumor characteristics, and prognosis: a prospective cohort of breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317698338

Estrogen receptors and human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317698338

Curcumin triggers p16-dependent senescence in active breast cancer-associated fibroblasts and suppresses their paracrine procarcinogenic effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317698338

Prognostic relevance of Ki-67 in the primary tumor for survival after a diagnosis of distant metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317698338

Association of tissue inhibitor of metalloproteinases-1 and Ki67 in estrogen receptor positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317698338

Prognostic value of Ki67 and p53 in patients with estrogen receptor-positive and human epidermal growth factor receptor 2-negative breast cancer: Validation of the cut-off value of the Ki67 labeling index as a predictive factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317698338

Antiangiogenic 1-Aryl-3-[3-(thieno[3,2-b]pyridin-7-ylthio)phenyl]ureas Inhibit MCF-7 and MDA-MB-231 Human Breast Cancer Cell Lines Through PI3K/Akt and MAPK/Erk Pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317698338

Hallmarks of Cancer: The Next Generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317698338

Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317698338

Sequence variants of the estrogen receptor (ER) gene found in breast cancer patients with ER negative and progesterone receptor positive tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317698338

21 January 2018

Identifiers

DOI

10.1177/1010428317698338

1 reference

2 September 2017

1 reference